Panel Discussion: Navigating VC Funding & Structuring Strategic Collaborations to Bridge Discovery & Clinical Translation in the European TPD Biotech Ecosystem

9:00 am - Thursday 12th March 2026

Understanding European VC expectations to enable biotechs to tailor fundraising strategies and secure investment in a competitive climate
Identifying how recent deals signal which emerging modalities – like novel ligases, non-oncology therapeutics, and going beyond the proteosome – investors are looking for as priorities evolve in the TPD space
Examining how early-stage proof-of-concept studies help validate platforms and increase commitment from pharma and VC partners
Exploring how early-stage collaborations between academic founders, biotechs, investors and university tech-transfer offices influence IP strategy, company creation, and translational readiness in Europe